Baidu
map

BMC Infect Dis:CMV基因组变异与有症状的感染和听力损失相关性研究

2020-01-01 AlexYang MedSci原创

新生儿巨细胞病毒感染(cCMV)是最常见的先天性感染,并且是长期神经和感觉后遗症的主要诱因,其中最常见的为感官听力损失(SNHL)。尽管已有大量的研究,鉴定疾病风险增加的CMV感染儿童的临床或者实验室标记仍旧还没有鉴定。最近,有研究人员进行了病毒全基因组测序(NGS)来探索病毒多样性和特定的病毒变异与有症状的感染和SNHL相关性情况。研究包括了从30个从婴儿尿液中提取的CMV DNA样。研究人员对

新生儿巨细胞病毒感染(cCMV)是最常见的先天性感染,并且是长期神经和感觉后遗症的主要诱因,其中最常见的为感官听力损失(SNHL)。尽管已有大量的研究,鉴定疾病风险增加的CMV感染儿童临床或者实验室标记仍旧还没有鉴定。最近,有研究人员进行了病毒全基因组测序(NGS)来探索病毒多样性和特定的病毒变异与有症状的感染和SNHL相关性情况。

研究包括了从30个从婴儿尿液中提取的CMV DNA样。研究人员对有症状和无症状cCMV儿童以及有听力损失(n=13)和没有听力损失(n=17)儿童中取的样进行了变异频率分布分析。研究发现,CMV基因UL48A、UL88、US19和US22在有症状儿童中核酸多样性增加;而UL57、UL20、UL104、US14、UL115和UL35在具有听力损失儿童中多样性增加。另外,对有症状儿童和无症状儿童的单变异差异分析发现了UL55变异频率最高,而大多数与SNHL相关的变异在RL11基因家族。在无症状SNHL儿童中,研究人员在UL33和UL20基因中观察到了更高频的变异。

最后,研究人员指出,来源于新生儿的CMV基因组可以覆盖93%的病毒基因组,具变异多态性的准确性和可重复性良好,并且有利于发现与有症状和听力损失结果有关系的基因。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-08-17 wolongzxh
  4. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]
    2020-01-03 ysjykql
  6. [GetPortalCommentsPageByObjectIdResponse(id=1974984, encodeId=32f719e498439, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Mar 20 22:50:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013133, encodeId=aa4e20131333a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Jun 08 21:50:00 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652662, encodeId=8af916526627c, content=<a href='/topic/show?id=0bb7491186' target=_blank style='color:#2F92EE;'>#CMV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4911, encryptionId=0bb7491186, topicName=CMV)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f5424318202, createdName=wolongzxh, createdTime=Mon Aug 17 05:50:00 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837774, encodeId=628f183e774e6, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Mar 04 18:50:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306466, encodeId=987213064662c, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342633, encodeId=65cc134263332, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Fri Jan 03 04:50:00 CST 2020, time=2020-01-03, status=1, ipAttribution=)]

相关资讯

Asia Pac J Clin Nutr:更高的血清镁离子浓度值与更低的听力阈值和听力损失风险相关

听力损失是一种感官障碍,由遗传和环境因素引起。之前对镁离子摄入和听力损失的流行病学研究结果存在矛盾。最近,有研究人员调查了中国浙江省人口中血清镁离子浓度与听力损失之间的关系。研究是一个代表性的研究,包括了年龄不小于18岁的3267名参与者,研究进行的时间为2016年10月到2018年5月。研究发现,线性回归模型阐释了血清镁离子浓度水平与听力损失在较低PTAs到高PTAs时存在负相关关系。调整了潜在

Sci Rep:听力能力不是老年人住院护理的一个风险因子

在许多国家,老年人住院护理(ARC)需求均超过了其自身承受能力,其中包括了新西兰。因此,鉴定能够预防或者延迟ARC接入的可改变因素具有重要的国际意义。听力损伤是老年人中常见的疾病,监管目前的证据仍旧比较模糊,但仍是一个重要的预测因子。最近,有研究人员使用最大的国家数据库,对具有标准家庭护理评估的34277名老年人进行了竞争风险回顾分析,时间为2012年7月到2014年5月,年龄≥65岁,并且在评估

盘点:近期听力损失盘点

【1】Metabolites:耳蜗移植患者外淋巴代谢组学与听力损失持续时间的关系研究 外淋巴代谢组学是改善人们对感觉神经性耳聋病理生理认识的一种新兴的创新方法。最近,有研究人员对人类外淋巴进行了代谢组学分析来评估代谢组与听力损失持续时间之间的关系。研究参与者的入选标准为符合耳蜗移植并在手术期间容易接近卵圆窗,排除了那些进行移植的耳蜗具有残余声学听力的患者。研究人员在耳蜗移植手术期间对

JAMA Otolaryngol Head Neck Surg:头颈癌患者放疗和顺铂化疗后听力损失预测研究

在头颈癌患者进行治疗之前,进行术后准确、易行的听力损失预测对患者进行治疗决定是必要的信息。最近,有研究人员对头颈癌患者开发了一种预测放疗后和/或者顺铂化疗后预测听力损失的模型。研究包括了242名头颈癌患者(482只耳朵,56名女性,平均年龄60(10)岁),并进行了回顾性的群体研究。所有包括在研究中的患者接受了放疗,105名患者(43.4%)接受了顺铂化疗。平均总的顺铂剂量为298(109)mg/

盘点:近期听力损失与治疗盘点

【1】Eur Arch Otorhinolaryngol:鼓室内infliximab给药是难治性免疫介导性听力损失的一种安全和有效的挽救疗法 最近,有研究人员确定了鼓室内infliximab给药对难治性免疫介导性听力损失跟踪调查患者听力阈值的效果和安全性情况。研究包括了17名复发患者,19只耳朵进行了infliximab给药。研究群体的平均年龄为50.68岁(±15.23岁)。在进行

JAMA Otolaryngol Head Neck Surg:成年耳蜗移植候选者术前评估和治疗中的听力实践

目前,没有明确的指南能够提供对成年人耳蜗移植(CI)候选者进行临床测试的方法。最近,有研究人员调查了美国听力学家在评估成年人CI候选者的术前测试方法情况。匿名调查中共有99响应者进行了反馈,因为调查是在网络上进行的,浏览了调查但没有回应的听力学家的数量是不清楚的。7名响应者为儿科专家,研究人员对其进行了排除。最后总共有92份调查可以用于分析(其中并非所有响应者都完成了调查问卷中的所有问题)。研究发

Baidu
map
Baidu
map
Baidu
map